Manipal Health Enterprises Limited reports Q2 and H1 FY2026-27 financial results
Manipal Health Enterprises · Healthcare Services
Key highlights
- Q2 revenue from operations at ₹3,399.35 crore; H1 revenue ₹6,489.98 crore; net profit ₹284.98 crore and ₹528.41 crore respectively
- Completed IPO in Q1, offering 157.23 million equity shares at ₹590/share, raising ₹8,000 crore fresh issue and ₹1,275 crore offer for sale
- Acquired Kinder Women’s Hospital business for ₹130 crore; purchased property at Juhu, Mumbai for ₹495 crore; entered 29-year lease in Gurugram
Original filing
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Unaudited Financial Results For Quarter And Half Year Ended 30.09.2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Manipal Health Enterprises
- Acquisition / mergerManipal Health Enterprises completes acquisition of Kinder Women’s Hospital
- Fundraise / allotmentNotableManipal Health Enterprises fully redeems ₹5,310 crore subsidiary NCDs from IPO proceeds
- Fundraise / allotmentNotable· Adverse for the businessManipal Health Enterprises Ltd shares pledged to secure NCDs via Vistra ITCL trustee
Other financial results filings this fortnight
- Financial resultsArvaya HealthcareArvaya Healthcare Ltd announces Q2 FY2026-27 financials, rights issue, and acquisition
- Financial resultsJindal PhotoJindal Photo Ltd files unaudited financial results and reports voluntary delisting
- Financial resultsGSP Crop ScienceGSP Crop Science Limited announces financial results and corporate updates for H1 FY 2026-27
- Financial resultsA-One Steels IndiaA-One Steels India Limited announces unaudited Q2 and half-year financial results for 2026
- Financial resultsNatural CapsulesNatural Capsules Limited approves Q2 FY27 financials and preferential allotment
- Financial resultsCapitalNumbers InfotechCapitalNumbers Infotech Limited announces unaudited H1 FY2026 financial results
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.